ResearcherFirst Hospital of China Medical UniversityActive in the last 2 years

Longping Huang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5054314473. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 3

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ming Dong · 2 shared papers, 2016–2024 · strength 0.34
- Paper MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression. DOI 10.1186/s12935-024-03444-9 ↗
- Paper Roles of Carbonic Anhydrase IX in Development of Pancreatic Cancer. DOI 10.1007/s12253-015-9935-6 ↗
Jian Hua Sun · 1 shared paper, 2024 · strength 0.26
- Paper MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression. DOI 10.1186/s12935-024-03444-9 ↗
Weiwei Sheng · 2 shared papers, 2016–2021 · strength 0.24
- Paper GINS2 promotes EMT in pancreatic cancer via specifically stimulating ERK/MAPK signaling. DOI 10.1038/s41417-020-0206-7 ↗
- Paper Roles of Carbonic Anhydrase IX in Development of Pancreatic Cancer. DOI 10.1007/s12253-015-9935-6 ↗
Yuji Li · 1 shared paper, 2016 · strength 0.08
- Paper Roles of Carbonic Anhydrase IX in Development of Pancreatic Cancer. DOI 10.1007/s12253-015-9935-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.